FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 139 filers reported holding FLEXION THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $610 | -50.6% | 100 | -33.3% | 0.00% | – |
| Q2 2021 | $1,235 | -8.0% | 150 | 0.0% | 0.00% | – |
| Q1 2021 | $1,343 | -22.4% | 150 | 0.0% | 0.00% | – |
| Q4 2020 | $1,731 | +10.8% | 150 | 0.0% | 0.00% | – |
| Q3 2020 | $1,562 | -20.8% | 150 | 0.0% | 0.00% | – |
| Q2 2020 | $1,973 | +67.1% | 150 | 0.0% | 0.00% | – |
| Q1 2020 | $1,181 | -62.0% | 150 | 0.0% | 0.00% | – |
| Q4 2019 | $3,105 | +51.0% | 150 | 0.0% | 0.00% | – |
| Q3 2019 | $2,056 | +11.4% | 150 | 0.0% | 0.00% | – |
| Q2 2019 | $1,845 | -1.4% | 150 | 0.0% | 0.00% | – |
| Q1 2019 | $1,872 | +10.2% | 150 | 0.0% | 0.00% | – |
| Q4 2018 | $1,698 | -39.5% | 150 | 0.0% | 0.00% | – |
| Q3 2018 | $2,807 | -27.6% | 150 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $3,878 | -13.5% | 150 | -25.0% | 0.00% | 0.0% |
| Q1 2018 | $4,482 | -10.5% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $5,008 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
| MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
| Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
| Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
| CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
| Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
| SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
| AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
| Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |